Showing results (361-370 of 456) with videos related to
Sort By:
Pageof 46
Gastroenterology|December 17, 2008
Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C virusesChun-Jen Liu, Wan-Long Chuang, Chuan-Mo Lee, et al.The Lancet. Gastroenterology & Hepatology|February 24, 2020
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority studyPietro Lampertico, Maria Buti, Scott Fung, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2021
Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks PosttreatmentChun Jen Liu, I Shyan Sheen, Chi Yi Chen, et al.Journal of Gastroenterology and Hepatology|November 22, 2025
FIB-4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLDYa-Chin Huang, Chih-Wen Wang, Jiun-Chi Huang, et al.Alimentary Pharmacology & Therapeutics|February 19, 2025
Air Pollution Associated With Mortality Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside AnaloguesTyng-Yuan Jang, Yu-Ting Zeng, Po-Cheng Liang, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 23, 2018
Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV InfectionWai-Kay Seto, Yasuhiro Asahina, Todd T Brown, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|November 21, 2022
A Phase 3 clinical trial validating the potency and safety of an innovative, extra-long-acting interferon in chronic hepatitis CChi-Yi Chen, Wan-Long Chuang, Albert Qin, et al.Journal of the Chinese Medical Association : JCMA|February 13, 2025
Air pollution causes abnormal alanine aminotransferase levels in patients with chronic hepatitis BTyng-Yuan Jang, Yu-Ting Zeng, Po-Cheng Liang, et al.The Kaohsiung Journal of Medical Sciences|November 10, 2023
Air pollution associate with advanced hepatic fibrosis among patients with chronic liver diseaseTyng-Yuan Jang, Chi-Chang Ho, Po-Cheng Liang, et al.JHEP Reports : Innovation in Hepatology|September 29, 2023
Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis BYoung-Suk Lim, Henry L Y Chan, Sang Hoon Ahn, et al.Pageof 46